Nektar Therapeutics NKTR EPS (Basic)

EPS (Basic) at other companies

AmgenAMGN

$4.40+65.4%

Regeneron PharmaceuticalsREGN

$12.62-4.7%

ImmunityBio, Inc.IBRX

-$0.62-313%

Apogee Therapeutics, Inc.APGE

-$1.06-11.6%

Artiva Biotherapeutics, Inc.ARTV

-$0.63+27.6%

CTO

Citius Oncology, Inc.CTOR

-$0.27-145%

FAQ

What is Nektar Therapeutics's EPS (basic)?

Nektar Therapeutics (NKTR) reported EPS (basic) of -$1.82 in Q1 2026.

How has Nektar Therapeutics's EPS (basic) changed year-over-year?

Nektar Therapeutics's EPS (basic) increased by 49.7% year-over-year, from -$3.62 to -$1.82.

What is the long-term trend for Nektar Therapeutics's EPS (basic)?

Over 4 years (2021 to 2025), Nektar Therapeutics's EPS (basic) has grown at a -66.5% compound annual growth rate (CAGR), from -$792.07 to -$10.03.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.